February 19, 2008 - A new study released today found pending congressional legislation seeking the mandatory disclosure of prices for certain medical technologies might result in increased prices and no tangible benefits to patients.

The study, released today at the National Press Club by its authors Robert W. Hahn, executive director, Reg-Markets Center and senior fellow at the American Enterprise Institute, and Hal J. Singer, president of Criterion Economics, examines the potential economic impact of the Transparency in Medical Device Pricing Act of 2007 (S. 2221), recently introduced in the U.S. Senate.

In the report, the researchers review previous attempts by governments to impose price disclosure rules in a number of other industries including cell phones, groceries, cement, barges, railroads and long-distance telephone services. The authors use evidence from case studies and other sources to identify four conditions that, if satisfied, imply that mandatory price disclosure would provide large benefits to consumers or other purchasers.

“We found that mandatory price disclosure, as proposed in S.2221 is unlikely to benefit patients or hospitals and worse, will likely increase costs,” Hahn said.

The authors write that in order for price disclosure to have a favorable effect, there must be large search costs that are reduced substantially, and that the pricing information disclosed be current. The industry-specific market conditions essential for lower prices to occur would require that any savings be passed on to end users, and that there is a large variation in the price paid by purchasers and consumers.

Specifically, the report found the medical device industry is concentrated among a few firms and competitors repeatedly interact in the marketplace. There are few, if any, economical substitutes for many medical devices. Some medical devices are standardized, whereas other devices are differentiated. The report also found that most of the firms do not already know their rivals’ prices.

The report conclude that significant search costs for hospitals and patients would remain and disclosure would not provide current price information, since the data would be at least three months old. The report also concluded the structure of the healthcare industry would not ensure that hospitals pass cost savings on to consumers.

“Applying these conditions to the medical device industry, we conclude that mandatory price disclosure policy would likely increase prices hospitals pay for these products and provide no tangible benefit to patients,” the authors said.

The study was supported by the Advanced Medical Technology Association.

For more information: www.criterioneconomics.com


Related Content

News | Cardiac Imaging

May 17, 2024 — The Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting found that the ...

Time May 17, 2024
arrow
News | Computed Tomography (CT)

September 19, 2023 — An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...

Time September 19, 2023
arrow
News | SPECT-CT

September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...

Time September 12, 2022
arrow
News | Contrast Media

August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...

Time August 02, 2022
arrow
News | Mobile C-Arms

July 29, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ...

Time July 29, 2022
arrow
News | Mobile C-Arms

January 18, 2022 – Philips Healthcare announced physicians will now have access to advanced new 3D image guidance ...

Time January 18, 2022
arrow
Feature | Mobile C-Arms | By Bhvita Jani

With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resources ...

Time July 07, 2021
arrow
News | Angiography

December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven angiography system for image guided ...

Time December 01, 2020
arrow
News | Mobile C-Arms

August 18, 2020 — Ziehm Imaging announces the acquisition of Therenva, a French-based developer of planning and imaging ...

Time August 18, 2020
arrow
News | Computed Tomography (CT)

February 10, 2020 — The U.S. Food and Drug Administration (FDA) has cleared patient-specific airway stents developed by ...

Time February 10, 2020
arrow
Subscribe Now